This study provides functional and mechanistic insights into the impact of Wilms tumor-associated ENL mutations on kidney development and offers a proof-of-concept for the use of epigenetics-targeted agents in the correction of developmental defects. This evidence concerns the gene MLLT1 and Wilms tumor.